NPCE

NeuroPace Inc

Feb 26 • 04:00PM ET

15.02

+0.30 2.04 %

Healthcare • Medical Devices • USA • NASD

Peers: MDT BSX SYK PODD LIVN NVRO EW ZBH ISRG STAA

| Held by: VTI IWM VXF IWO VTWO IWC PSC VTWG GSSC RSSL

Index	RUT	P/E	-	EPS (ttm)	-0.75	Insider Own	24.75%	Shs Outstand	33.28M	Perf Week	3.66%
Market Cap	500.28M	Forward P/E	-	EPS next Y	-0.76	Insider Trans	0.00%	Shs Float	25.07M	Perf Month	-5.83%
Enterprise Value	511.45M	PEG	-	EPS next Q	-0.16	Inst Own	75.17%	Short Float	3.47%	Perf Quarter	-7.63%
Income	-23.99M	P/S	5.27	EPS this Y	17.72%	Inst Trans	6.81%	Short Ratio	4.18	Perf Half Y	67.45%
Sales	94.86M	P/B	26.99	EPS next Y	1.17%	ROA	-23.57%	Short Interest	0.87M	Perf YTD	-2.72%
Book/sh	0.56	P/C	8.34	EPS next 5Y	23.62%	ROE	-169.27%	52W High	18.98 -20.84%	Perf Year	11.42%
Cash/sh	1.80	P/FCF	-	EPS past 3/5Y	14.21% 5.83%	ROIC	-27.37%	52W Low	7.56 98.61%	Perf 3Y	202.21%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	20.93% 16.67%	Gross Margin	76.77%	Volatility	3.37% 4.92%	Perf 5Y	-
Dividend TTM	-	EV/Sales	5.39	EPS Y/Y TTM	24.08%	Oper. Margin	-19.21%	ATR (14)	0.72	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	3.94	Sales Y/Y TTM	24.08%	Profit Margin	-25.28%	RSI (14)	47.35	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	4.86	EPS Q/Q	43.03%	SMA20	-0.55%	Beta	1.86	Target Price	19.50
Payout	-	Debt/Eq	3.84	Sales Q/Q	29.89%	SMA50	-4.99%	Rel Volume	0.57	Prev Close	14.72
Employees	184	LT Debt/Eq	3.73	Earnings	Mar 03 AMC	SMA200	19.74%	Avg Volume	207.88K	Price	15.02
IPO	Apr 22, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	43.68% 11.02%	Trades		Volume	121,264	Change	2.04%

Date	Action	Analyst	Rating Change	Price Target Change
May-28-25	Initiated	H.C. Wainwright	Buy	$18
Jan-21-25	Initiated	UBS	Buy	$17
Mar-14-24	Upgrade	Wells Fargo	Equal Weight → Overweight	$16 → $20
Jan-30-24	Initiated	Leerink Partners	Outperform	$22
Nov-10-23	Initiated	Cantor Fitzgerald	Overweight	$11
Aug-24-23	Upgrade	Morgan Stanley	Underweight → Equal-Weight	$5 → $6
Feb-22-23	Initiated	Lake Street	Buy	$10
Apr-06-22	Initiated	Wolfe Research	Outperform	$13
Jan-19-22	Downgrade	Wells Fargo	Overweight → Equal Weight	$11
Jan-07-22	Downgrade	Morgan Stanley	Equal-Weight → Underweight	$17 → $12
Nov-11-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Aug-18-21	Initiated	Robert W. Baird	Outperform	$26
May-17-21	Initiated	Wells Fargo	Overweight	$25
May-17-21	Initiated	SVB Leerink	Outperform	$25
May-17-21	Initiated	Morgan Stanley	Overweight	$26
May-17-21	Initiated	JP Morgan	Overweight	$27

Show Previous Ratings

Feb-25-26 12:15PM	LivaNova (LIVN) Tops Q4 Earnings and Revenue Estimates (Zacks)
10:00AM	Sight Sciences, Inc. (SGHT) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
Feb-24-26 10:00AM	NeuroPace, Inc. (NPCE) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
Feb-20-26 04:30PM	NeuroPace to Report Fourth Quarter 2025 Financial Results on March 3, 2026 (Business Wire)
Feb-12-26 05:35PM	Pacific Biosciences of California (PACB) Reports Q4 Loss, Beats Revenue Estimates (Zacks)
07:30AM	Loading…
Jan-13-26 07:30AM	NeuroPace Reports Preliminary Unaudited Results for the Fourth Quarter and Fiscal Year 2025 and Initial 2026 Outlook (Business Wire)
Dec-31-25 09:00AM	NeuroPace to Present at the 44th Annual J.P. Morgan Healthcare Conference (Business Wire)
Dec-17-25 08:00AM	NeuroPace Files PMA Supplement to FDA Seeking Expanded RNS System Indication for Idiopathic Generalized Epilepsy (Business Wire)
Dec-08-25 08:00AM	NeuroPace Announces Positive 18-Month NAUTILUS Trial Results in Idiopathic Generalized Epilepsy (Business Wire)
Dec-02-25 08:01AM	NeuroPace to Highlight Life-Changing Outcomes and AI-Powered Confident Care at the 2025 American Epilepsy Society (AES) Annual Meeting (Business Wire)
Nov-24-25 08:00AM	NeuroPace Announces Favorable Medicare Reimbursement Increases for RNS System Physician and Hospital Outpatient Services (Business Wire) +13.31%
Nov-05-25 12:04AM	NeuroPace Inc (NPCE) Q3 2025 Earnings Call Highlights: Record Revenue and Positive EBITDA Milestone (GuruFocus.com) +38.09%
Nov-04-25 06:20PM	NeuroPace, Inc. (NPCE) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
05:17PM	NeuroPace Inc.: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	NeuroPace Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance (Business Wire)
08:04AM	Loading…
Nov-03-25 08:04AM	NeuroPace Inc (NPCE) Q3 2025 Earnings Report Preview: What to Look For (GuruFocus.com) -5.43%
Oct-22-25 08:00AM	NeuroPace to Report Third Quarter 2025 Financial Results on November 4, 2025 (Business Wire)
Aug-28-25 08:00AM	NeuroPace to Participate in Upcoming Healthcare Conferences (Business Wire)
Aug-13-25 03:13AM	NeuroPace Inc (NPCE) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ... (GuruFocus.com)
Aug-12-25 05:25PM	NeuroPace, Inc. (NPCE) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
04:35PM	NeuroPace Inc.: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	NeuroPace Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance (GlobeNewswire)
Aug-11-25 09:35AM	Earnings To Watch: NeuroPace Inc (NPCE) Reports Q2 2025 Result (GuruFocus.com)
Aug-07-25 05:40PM	Stereotaxis Inc. (STXS) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
Aug-06-25 05:45PM	PROCEPT BioRobotics Corporation (PRCT) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
Aug-05-25 08:25AM	Orthofix (OFIX) Q2 Earnings and Revenues Beat Estimates (Zacks)
Aug-01-25 07:30AM	NeuroPace Commends CMS for Maintaining FY25 Reimbursement Structure for Epilepsy with Neurostimulator Cases (GlobeNewswire) +5.64%
Jul-29-25 04:05PM	NeuroPace to Report Second Quarter 2025 Financial Results on August 12, 2025 (GlobeNewswire)
Jul-15-25 07:40AM	AngioDynamics (ANGO) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
Jun-24-25 04:05PM	NeuroPace Announces Strategic CFO Transition (GlobeNewswire)
01:35PM	Loading…
Jun-17-25 01:35PM	NeuroPace, Inc. (NPCE) Backed by Cantor Fitzgerald Following Physician Survey (Insider Monkey)
Jun-04-25 04:09PM	NeuroPace Secures Up to $75 Million in Debt Financing (GlobeNewswire)
May-29-25 02:48PM	H.C. Wainwright Initiates Coverage of NeuroPace (NPCE) With Buy Rating (Insider Monkey) +5.22%
May-28-25 11:50AM	NPCE Stock Tumbles Despite Positive One-Year Data From NAUTILUS Trial (Zacks)
10:45AM	NeuroPace reports initial one-year outcomes from trial of RNS System (Medical Device Network)
May-27-25 12:48PM	Why Is NeuroPace Stock Falling After Epilepsy Treatment Study Data? (Benzinga) -28.39%
08:00AM	NeuroPace Announces Preliminary Results from One-Year Data in NAUTILUS Study (GlobeNewswire)
May-15-25 08:06AM	5 High-Flying Medical Instrument Stocks to Buy Despite Recent Turmoil (Zacks) +9.49%
May-14-25 12:56PM	Q1 2025 Neuropace Inc Earnings Call (Thomson Reuters StreetEvents) +20.46%
03:15AM	NeuroPace Inc (NPCE) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
May-13-25 05:25PM	NeuroPace, Inc. (NPCE) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:23PM	NeuroPace Inc.: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	NeuroPace Reports First Quarter 2025 Financial Results (GlobeNewswire)
08:50AM	Recent Price Trend in NeuroPace (NPCE) is Your Friend, Here's Why (Zacks)
May-12-25 05:15PM	DaVita HealthCare (DVA) Q1 Earnings and Revenues Beat Estimates (Zacks)
09:33AM	NeuroPace Inc (NPCE) Q1 2025 Earnings Report Preview: What To Look For (GuruFocus.com)
May-09-25 08:20AM	Rapid Micro Biosystems, Inc. (RPID) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
May-08-25 06:15PM	Treace Medical Concepts (TMCI) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
May-05-25 05:30PM	Tactile Systems Technology (TCMD) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
Apr-14-25 04:05PM	NeuroPace Provides Update on Tariff Status (GlobeNewswire)
Apr-08-25 08:00AM	NeuroPace Announces Data From a Long-Term Post-Approval Study of the RNS System in Focal Epilepsy at the 2025 AAN Annual Meeting (GlobeNewswire) -9.76%
Apr-03-25 08:00AM	NeuroPace Announces Upcoming Oral Presentation of Data from the Long-Term Post-Approval Study of the RNS System at the 2025 AAN Annual Meeting (GlobeNewswire)
Apr-02-25 04:05PM	NeuroPace Announces Refocusing of Product Portfolio (GlobeNewswire)
Mar-26-25 08:00AM	NeuroPace to Present at the 24th Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-05-25 06:49AM	Q4 2024 Neuropace Inc Earnings Call (Thomson Reuters StreetEvents)
02:09AM	NeuroPace Inc (NPCE) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ... (GuruFocus.com)
Mar-04-25 04:24PM	NeuroPace Inc.: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	NeuroPace Reports Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Mar-03-25 09:15PM	UPDATE NeuroPace to Present at the Leerink Partners Global Healthcare Conference (GlobeNewswire) -8.80%
04:05PM	NeuroPace to Present at the Leerink Partners Global Healthcare Conference (GlobeNewswire)
07:14AM	NeuroPace Inc (NPCE) Q4 2024 Earnings Report Preview: What to Look For (GuruFocus.com)
Feb-21-25 05:13AM	NeuroPace (NPCE) Surges 5.8%: Is This an Indication of Further Gains? (Zacks)
Feb-20-25 04:05PM	NeuroPace Completes Repurchase of 5.3 Million Shares of Its Common Stock from KCK Ltd. (GlobeNewswire) +5.80%
Feb-19-25 04:05PM	NeuroPace to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025 (GlobeNewswire)
Feb-18-25 04:05PM	NeuroPace Announces Completion of Public Offering of Common Stock and Exercise in Full of Underwriters' Option to Purchase Additional Shares (GlobeNewswire) +9.18%
Feb-14-25 08:12AM	NeuroPace Prices $65 Million Offering; Shares Drop in Pre-Market (GuruFocus.com)
06:33AM	NeuroPace Announces Pricing of Public Offering of $65 Million of Common Stock (GlobeNewswire)
Feb-13-25 04:34PM	NeuroPace Announces Proposed Public Offering of $65 Million of Common Stock (GlobeNewswire)
Feb-03-25 04:05PM	NeuroPace Announces Upcoming Oral Presentation of Data from the Post-Approval Study of the RNS System at the American Academy of Neurology 2025 Annual Meeting Being Held April 5th 9th (GlobeNewswire)
Jan-28-25 05:15PM	NeuroPace Issues 2025 Financial Guidance Targets (GlobeNewswire)
Jan-22-25 05:32AM	NeuroPace (NPCE) Soars 9.1%: Is Further Upside Left in the Stock? (Zacks) +7.50%
Jan-08-25 04:05PM	NeuroPace Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2024 and Provides Business Updates (GlobeNewswire)
Dec-25-24 12:00PM	NeuroPace (NPCE) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
Dec-18-24 04:05PM	NeuroPace to Present at the 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire) -7.64%
Dec-12-24 04:05PM	NeuroPace to Host Investor Day on January 28th in New York City (GlobeNewswire)
Dec-06-24 09:55AM	Wall Street Analysts Think NeuroPace (NPCE) Could Surge 31.47%: Read This Before Placing a Bet (Zacks)
Dec-04-24 04:05PM	NeuroPace to Showcase the RNS System at the 2024 American Epilepsy Society (AES) Annual Meeting (GlobeNewswire) -6.20%
Dec-03-24 04:05PM	NeuroPace Completes Enrollment in Feasibility Study of RNS System for Lennox-Gastaut Syndrome (GlobeNewswire) +5.67%
Nov-18-24 12:00PM	What Makes NeuroPace (NPCE) a New Buy Stock (Zacks)
09:55AM	Wall Street Analysts Believe NeuroPace (NPCE) Could Rally 54.34%: Here's is How to Trade (Zacks)
Nov-13-24 02:18AM	NeuroPace Inc (NPCE) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth ... (GuruFocus.com) +28.15%
Nov-12-24 06:00PM	NeuroPace, Inc. (NPCE) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
04:54PM	NeuroPace Inc.: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	NeuroPace Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue Guidance (GlobeNewswire)
Nov-11-24 07:18AM	Earnings To Watch: NeuroPace Inc (NPCE) Reports Q3 2024 Result (GuruFocus.com)
Nov-04-24 04:05PM	NeuroPace Announces FDA Submission of Three-Year Data from Post-Approval Study of the RNS System in Focal Epilepsy (GlobeNewswire) +9.73%
Oct-28-24 09:08PM	KCK LTD.'s Strategic Reduction in NeuroPace Inc Shares (GuruFocus.com)
08:04AM	Strength Seen in NeuroPace (NPCE): Can Its 5.1% Jump Turn into More Strength? (Zacks)
Oct-24-24 09:08PM	KCK LTD. Adjusts Stake in NeuroPace Inc (GuruFocus.com) +5.13%
Oct-22-24 04:05PM	NeuroPace to Report Third Quarter 2024 Financial Results on November 12, 2024 (GlobeNewswire)
03:01PM	KCK LTD.'s Strategic Reduction in NeuroPace Inc Shares (GuruFocus.com)
Oct-18-24 03:01PM	KCK LTD. Reduces Stake in NeuroPace Inc (GuruFocus.com)
Oct-16-24 04:05PM	NeuroPace Continues to Strengthen Management Team (GlobeNewswire)
Oct-03-24 07:04PM	KCK LTD. Reduces Stake in NeuroPace Inc (GuruFocus.com)
Sep-04-24 04:05PM	NeuroPace Strengthens Management Team with Two Key Appointments (GlobeNewswire)
Aug-27-24 04:05PM	NeuroPace Announces Participation at Two Upcoming Healthcare Investor Conferences (GlobeNewswire)
Aug-22-24 04:05PM	NeuroPace to Participate in Upcoming Healthcare Conferences in September (GlobeNewswire) -5.65% +12.98%
Aug-20-24 07:37AM	NeuroPace (NPCE) Q2 Earnings Beat, '24 Sales View Up (Zacks)
Aug-13-24 04:05PM	NeuroPace Reports Second Quarter 2024 Financial Results and Increases 2024 Revenue Guidance (GlobeNewswire) +5.51% -7.01%
Jul-23-24 04:05PM	NeuroPace to Report Second Quarter 2024 Financial Results on August 13, 2024 (GlobeNewswire) +10.59%

NeuroPace, Inc. develops, manufactures, and markets implantable devices for treating epilepsy and neurological disorders. It offers implantable components, which include the RNS neurostimulator as well as depth and cortical strip leads. The firm's RNS System is designed for the treatment of medically refractory partial epilepsy and includes implantable and external products. The company was founded by Rebecca L. Kuhn, Frank M. Fischer on November 19, 1997 and is headquartered in Mountain View, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
MARTHA J MORRELL	Officer	Dec 15 '25	Proposed Sale	16.19	25,000	404,750		Dec 15 04:26 PM
ORBIMED ADVISORS LLC	10% Owner	May 14 '25	Sale	15.85	168,136	2,665,333	3,238,199	May 16 05:26 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NPCE

NeuroPace Inc

Upgrade your FINVIZ experience